ArticleFrontiers in nutrition2025
Fully hydrogenated vegetable oil-based non-dairy creamer intake impairs athletic performance in mice: serum metabolomics and intestinal microbiota analyses.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Fully hydrogenated vegetable oil-based non-dairy creamer (FHVO-NDC) is produced through complete hydrogenation of vegetable oil, resulting in a trans fat-free product commonly incorporated into sports foods and performance-oriented beverages. Because diet plays a crucial role in shaping athletic performance, understanding the potential physiological effects of FHVO-NDC is essential for athletes and fitness enthusiasts. However, the combined impact of FHVO-NDC on muscle physiology, serum metabolomic alterations, and gut microbiota has not been evaluated. Therefore, the objective of this study was to address this knowledge gap using a controlled mouse model. Methods: Experimental animals were assigned to two groups: a control group receiving regular water and a treatment group receiving water supplemented with FHVO-NDC. Multiple physiological and biochemical parameters were monitored, including body condition ( Results: FHVO-NDC intake did not alter body condition or feeding behavior. However, it resulted in a measurable decline in athletic performance. This reduction was accompanied by decreased myofiber diameter ( Discussion: Collectively, these findings suggest that FHVO-NDC consumption may exert detrimental effects on muscle physiology and athletic performance in the mouse model. The observed alterations in muscle traits, serum metabolites, and gut microbiota highlight potential biological mechanisms through which FHVO-NDC could negatively influence exercise capacity, warranting further investigation regarding its implications for athletes and physically active individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.